Norway Savings Bank - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Norway Savings Bank ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$214,363
-24.2%
5,680
-8.5%
0.11%
-31.2%
Q2 2023$282,700
+8.7%
6,205
-3.3%
0.15%
+17.6%
Q1 2023$260,192
-20.4%
6,4150.0%0.13%
-21.1%
Q4 2022$326,973
-7.9%
6,415
-2.7%
0.17%
-14.4%
Q3 2022$355,000
-16.5%
6,595
-0.2%
0.19%
-11.8%
Q2 2022$425,000
-19.8%
6,610
-3.3%
0.22%
-7.9%
Q1 2022$530,000
-10.0%
6,835
-0.4%
0.24%
-7.4%
Q4 2021$589,000
+3.9%
6,860
-2.8%
0.26%
-3.4%
Q3 2021$567,000
-3.6%
7,055
-3.4%
0.27%
-6.6%
Q2 2021$588,000
-4.7%
7,305
-0.2%
0.29%
-12.0%
Q1 2021$617,000
+1.6%
7,320
-3.2%
0.32%
-6.6%
Q4 2020$607,000
-0.2%
7,5650.0%0.35%
-15.3%
Q3 2020$608,000
-7.6%
7,565
-1.0%
0.41%
-15.1%
Q2 2020$658,000
+6.1%
7,6400.0%0.48%
-10.4%
Q1 2020$620,000
-4.0%
7,640
-1.0%
0.54%
+15.1%
Q4 2019$646,000
-5.0%
7,720
-0.6%
0.47%
-15.3%
Q3 2019$680,000
+5.4%
7,770
-1.4%
0.55%
+0.9%
Q2 2019$645,000
+0.2%
7,880
-0.5%
0.55%
-3.2%
Q1 2019$644,000
+19.7%
7,920
-3.1%
0.57%
+7.6%
Q4 2018$538,000
-18.7%
8,170
-4.9%
0.53%
-8.7%
Q3 2018$662,000
-17.5%
8,590
-20.9%
0.58%
-21.2%
Q2 2018$802,000
+13.1%
10,865
-0.4%
0.73%
+9.4%
Q1 2018$709,000
-1.7%
10,905
-2.2%
0.67%
-1.2%
Q4 2017$721,000
+3.0%
11,1500.0%0.68%
+0.9%
Q3 2017$700,000
+1.9%
11,150
-1.7%
0.67%0.0%
Q2 2017$687,000
+16.8%
11,3450.0%0.67%
+11.1%
Q1 2017$588,000
+3.7%
11,345
-11.3%
0.60%
+14.4%
Q4 2016$567,00012,7900.53%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders